HiemkeC, BergemannN, ClementH, et al.Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: Update 2017. Pharmacopsychiatry, 2018; 51(01/02):9–62; doi: 10.1055/s-0043-116492
2.
HsuC-W, LeeY, LeeC-Y, et al.Neurotoxicity and nephrotoxicity caused by combined use of lithium and risperidone: A case report and literature review. BMC Pharmacol Toxicol, 2016; 17:59; doi: 10.1186/s40360-016-0101-x
3.
JukicMM, SmithRL, HaslemoT, et al.Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: A retrospective, cohort study. Lancet Psychiatry, 2019; 6(5):418–426; doi: 10.1016/S2215-0366(19)30088-4
4.
VandenbergheF, GuidiM, ChoongE, et al.Genetics-based population pharmacokinetics and pharmacodynamics of risperidone in a psychiatric cohort. Clin Pharmacokinet, 2015; 54(12):1259–1272; doi: 10.1007/s40262-015-0289-8
